MIEGX
Price
$10.40
Change
-$0.10 (-0.95%)
Updated
Sep 6 closing price
RNWFX
Price
$79.55
Change
-$1.12 (-1.39%)
Updated
Sep 6 closing price
Ad is loading...

MIEGX vs RNWFX

Header iconMIEGX vs RNWFX Comparison
Open Charts MIEGX vs RNWFXBanner chart's image
BNY Mellon Emerging Markets I
Price$10.40
Change-$0.10 (-0.95%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$79.55
Change-$1.12 (-1.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MIEGX vs RNWFX Comparison Chart
Loading...
VS
MIEGX vs. RNWFX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIEGX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.1B vs. MIEGX (209M). RNWFX pays higher dividends than MIEGX: RNWFX (1.51) vs MIEGX (1.30). MIEGX was incepted earlier than RNWFX: MIEGX (23 years) vs RNWFX (22 years). MIEGX is a more actively managed with annual turnover of: 121.64 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than MIEGX: RNWFX (250) vs MIEGX (10000). RNWFX annual gain was more profitable for investors over the last year : 11.53 vs. MIEGX (7.96). RNWFX return over 5 years is better than : 22.38 vs. MIEGX (7.94).
MIEGXRNWFXMIEGX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years22 years-
Gain YTD2.7407.24538%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRA10000N/A-
Net Assets209M60.1B0%
Annual Yield % from dividends1.301.5186%
Returns for 1 year7.9611.5369%
Returns for 3 years-22.35-15.44145%
Returns for 5 years7.9422.3836%
Returns for 10 years1.2835.714%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGO16.410.29
+1.80%
Eldorado Gold Corp
BIP31.38-0.08
-0.25%
Brookfield Infrastructure Partners LP
KTRA0.17N/A
-2.51%
Kintara Therapeutics
LCTX0.87-0.03
-3.17%
Lineage Cell Therapeutics
NUVB2.88-0.13
-4.32%
Nuvation Bio